Hypermethylation of RUFY1 associated with high risks of schizophrenia and poor treatment responses in Han Chinese
Weihua Yue, China
Frontal-posterior functional imbalance and aberrant function developmental patterns in schizophrenia
Fei Wang, China
The role of white blood cell counts in metabolic changes and clinical symptom improvement after antipsychotics in patients with schizophrenia: evidence from a large Chinese cohort
Yamin Zhang, China
Developing new drugs for schizophrenia: Mechanism study of fingolimod and a novel AMPA receptor positive allosteric modulator LT-102 as therapeutic agents for facilitating cognitive function in schizophrenia model
Xueli Yu, China
Chairperson: Tao Li, China
